A Crossover Study to Assess the Drug-drug Interaction of Acid Reducing Agent(s) on the Pharmacokinetics of a Single Oral Dose of Lumicitabine (JNJ-64041575) in Healthy Adult Participants
Clinical trial NCT03468777 · TERMINATED
Trial details
- NCT number
- NCT03468777
- Sponsor
- Janssen Research & Development, LLC
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-06
- Primary completion
- 2018-07-09
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.